We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$214M
AUM Growth
-$55.1M
Cap. Flow
-$57.5M
Cap. Flow %
-26.83%
Top 10 Hldgs %
32.55%
Holding
81
New
13
Increased
14
Reduced
26
Closed
22

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$5.49M
2
TMO icon
Thermo Fisher Scientific
TMO
+$4.2M
3
RVTY icon
Revvity
RVTY
+$3.48M
4
TECH icon
Bio-Techne
TECH
+$2.83M
5
NVRO
NEVRO CORP.
NVRO
+$2.83M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$6.09M
2
HCA icon
HCA Healthcare
HCA
+$5.82M
3
CELG
Celgene Corp
CELG
+$5.22M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.72M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.19M

Sector Composition

Rank Sector Weight
1 Healthcare 95.03%
2 Energy 1.01%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
26
Incyte
INCY
$24.5B
$3.75M 1.75%
45,000
-25,000
-36% -$2.25M
RVTY icon
27
Revvity
RVTY
$12.9B
$3.41M 1.59%
+45,000
New +$3.48M
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
$3.34M 1.56%
30,000
-10,000
-25% -$1.2M
ZTS icon
29
Zoetis
ZTS
$31.1B
$3.34M 1.56%
40,000
-20,000
-33% -$1.58M
NVRO
30
DELISTED
NEVRO CORP.
NVRO
$3.03M 1.42%
+35,000
New +$2.83M
TECH icon
31
Bio-Techne
TECH
$11.2B
$3.02M 1.41%
+80,000
New +$2.83M
A icon
32
Agilent Technologies
A
$42.2B
$2.68M 1.25%
+40,000
New +$2.8M
XENT
33
DELISTED
Intersect ENT, Inc
XENT
$2.56M 1.19%
+65,000
New +$2.37M
FMS icon
34
Fresenius Medical Care
FMS
$12.7B
$2.55M 1.19%
+50,000
New +$2.67M
NBIX icon
35
Neurocrine Biosciences
NBIX
$16.5B
$2.49M 1.16%
30,000
-5,000
-14% -$422K
HCA icon
36
HCA Healthcare
HCA
$89.1B
$2.42M 1.13%
25,000
-60,000
-71% -$5.82M
QGEN icon
37
Qiagen
QGEN
$8.81B
$2.42M 1.13%
+70,729
New +$2.48M
MCK icon
38
McKesson
MCK
$105B
$2.42M 1.13%
17,187
-12,813
-43% -$2M
SAGE
39
DELISTED
Sage Therapeutics
SAGE
$2.42M 1.13%
15,000
-5,000
-25% -$849K
SRPT icon
40
Sarepta Therapeutics
SRPT
$1.92B
$2.22M 1.04%
30,000
– –
BDX icon
41
Becton Dickinson
BDX
$49.4B
$2.17M 1.01%
10,250
-7,214
-41% -$1.58M
LHCG
42
DELISTED
LHC Group LLC
LHCG
$2.15M 1.01%
35,000
-15,000
-30% -$947K
BHC icon
43
Bausch Health
BHC
$2.33B
$2.07M 0.97%
130,000
+30,000
+30% +$558K
CHE icon
44
Chemed
CHE
$7.02B
$2.05M 0.95%
7,500
-2,500
-25% -$662K
LOXO
45
DELISTED
Loxo Oncology, Inc
LOXO
$2.02M 0.94%
17,500
– –
HAE icon
46
Haemonetics
HAE
$3.97B
$1.97M 0.92%
+26,893
New +$1.85M
ZBH icon
47
Zimmer Biomet
ZBH
$18.5B
$1.94M 0.91%
18,331
-28,019
-60% -$3.25M
COR icon
48
Cencora
COR
$63.7B
$1.94M 0.91%
22,500
-37,500
-63% -$3.6M
AVXS
49
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.85M 0.87%
15,000
-5,000
-25% -$594K
BPMC
50
DELISTED
Blueprint Medicines
BPMC
$1.83M 0.86%
20,000
– –
1
2
3 4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q1 2018 Portfolio in Review

As of Q1 2018, Sivik Global Healthcare held 81 positions worth $214M, down 20% from $269M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Sivik Global Healthcare withdrew a net $57.5M in Q1 2018, closing 22 positions and reducing 26 holdings. Its most notable exit was Cigna, an estimated $6.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 93% a quarter earlier, followed by Energy and Financials.

Against the trend, Sivik Global Healthcare opened a new position in Cardinal Health worth $5.01M.

  • Sivik Global Healthcare's largest Q1 2018 buy was Cardinal Health: 80,000 shares worth $5.01M.
  • Sivik Global Healthcare added most to Viatris in Q1 2018, an estimated $1.71M increase.
  • Sivik Global Healthcare's biggest Q1 2018 reduction was HCA Healthcare, cutting an estimated $5.82M.
  • Sivik Global Healthcare fully exited Cigna in Q1 2018, selling an estimated $6.09M.
  • Sivik Global Healthcare's ten largest holdings make up 33% of its $214M portfolio in Q1 2018.
  • Sivik Global Healthcare opened 13 new positions and closed 22 in Q1 2018.
  • Sivik Global Healthcare's portfolio value fell 20% quarter-over-quarter to $214M.

Based on Sivik Global Healthcare's 13F filing for Q1 2018, filed 8 May 2018.